Calluna Pharma

Norway
Oslo, Oslo, Norway, 0250

Company profile

Calluna Pharma company profile

Calluna has developed a robust pipeline of selective antibodies, targeting immunological diseases. These include novel therapeutic candidates that fulfill unmet clinical needs across a spectrum of diseases.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2024-01-01, Year

Headquarters

Headquarters
Oslo, Oslo, Norway
Postal code
0250
Country code
NO
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$81.4M
Last funding
Series A / $81.4M / 2024-01-23
Last equity funding
Series A / $81.4M
Investors
4
Articles
25

Founders and investors

Investors

Forbion Capital PartnersInvestinorp53Sarsia